themselves, as they were not investigated alone. Since HCA
was not effective in this study, it is possible that the possible
effect of MCT was inhibited.
We gratefully acknowledge Miranda de Vries, Joan Senden, and
Paul Schoffelen for their assistance. This study was supported
by Novartis Consumer Health Ltd, Nyon, Switzerland.
1 Seidell JC. Obesity in Europe. Obes Res 1995; 3(Suppl 2): 249s±259s.
2 Flatt JP, Ravussin E, Acheson KJ, Je
quier E. Effects of dietary fat on
postprandial substrate oxidation and on carbohydrate and fat
balances. J Clin Invest 1985; 76: 1019±1024.
3 Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an
independent risk factor for cardiovascular disease: a 26-year
follow-up of participants in the Framingham Heart Study. Circu-
lation 1983; 67: 968±977.
4 Kromhout D. Body weight, diet, and serum cholesterol in 871
middle-aged men during 10 years of follow-up (the Zutphen
Study). Am J Clin Nutr 1983; 38: 591±598.
5 Noppa H. Body weight change in relation to incidence of
ischemic heart disease and change in risk factors for ischemic
heart disease. Am J Epidemiol 1980; 111: 693±704.
6 Fogelholm M, Kukkonen-Harjula K, Oja P. Eating control and
physical activity as determinants of short-term weight main-
tenance after a very-low-calorie diet among obese women. Int J
Obes Relat Metab Disord 1999; 23: 203±210.
7 Pasman WJ, Saris WHM, Westerterp-Plantenga MS. Predictors of
weight maintenance. Obes Res 1999; 7: 43±50.
8 Westerterp-Plantenga MS, Kempen KP, Saris WHM. Determinants
of weight maintenance in women after diet-inducecd weight
reduction. Int J Obes Relat Metab Disord 1998; 22: 1±6.
9 Langhans W. Metabolic control of food intake. Role of the liver.
In: Westerterp-Plantenga MS, Steffen AB, Tremblay A (eds). Reg-
ulation of food intake and energy expenditure. EDRA: Milano; 1999.
10 Furuse M, Choi YH, Mabayo RT, Okumura JI. Feeding behavior in
rats fed diets containing medium chain triglyceride. Physiol Behav
1992; 52: 815±817.
11 Jeukendrup AE, Saris WHM, Wagenmakers AJM. Fat metabolism
during exercise: a review. Part III: The effects of nutritional
interventions. Int J Sports Med 1998; 19: 371±379.
12 McCarty MF. Reduction of free fatty acids may ameliorate risk
factors associated with abdominal obesity. Med Hypotheses 1995;
13 Rolls BJ, Gnisak N, Summerfeld A, Laster LJ. Food intake in dieters
and nondieters after a liquid meal containing medium-chain
triglycerides. Am J Clin Nutr 1988; 48: 66±71.
14 Satabin P, Auclair E, Servan E, Achagiotis CL, Guezennec CY.
In¯uence of glucose, medium-chain and long-chain triglyceride
gastric loads and forced exercise on food intake and body weight
in rats. Physiol Behav 1991; 50: 147±150.
15 Stubbs RJ, Harbron CG. Covert manipulation of the ratio of
medium- to long-chain triglycerides in isoenergetically dense
diets: effect on food intake in ad libitum feeding men. Int J Obes
Relat Metab Disord 1996; 20: 435±444.
16 Sullivan AC, Triscari J. Metabolic regulators as a control for lipid
disorders. I. In¯uence of (ÿ)-hydroxycitrate on experimentally
induced obesity in the rodent. Am J Clin Nutr 1977; 30: 767±776.
17 Watson JA, Fang M, Lowenstein JM. Tricaballylate and hydro-
xycitrate: substrate and inhibitor of ATP: citrate oxaloacetate
lyase. Arch Biochem Biophys 1969; 135: 209±217.
18 Sullivan AC, Hamilton JG, Miller ON, Wheatley VR. Inhibition of
lipogenesis in rat liver by (ÿ)-hydroxycitrate. Arch Biochem Bio-
phys 1972; 150: 183±190.
19 Szutowicz A, Stepien M, Lysiak W, Angielski S. Effect of (ÿ)-
hydroxycirate on the activities of ATP citrate lyase and the
enzymes of acetyl-CoA metabolism in rat brain. Acta Biochim
Pol 1976; 23: 227±234.
20 McCarty MF. Promotion of hepatic lipid oxidation and gluconeo-
genesis as a strategy for appetite control. Med Hypotheses 1994; 42:
21 McGarry JD, Foster DW. In support of the roles of malonyl-CoA
and carnitine acyltransferase I in the regulation of hepatic fatty
acid oxidation and ketogenesis. J Biol Chem 1979; 254: 8163±
22 Hellerstein MK, Xie Y. The indirect pathway of hepatic glycogen
synthesis and reduction of food intake by metabolic inhibitors.
Life Sci 1993; 53: 1833±1845.
23 Badmaev V, Majeed M, Conte AA. Garcinia cambogia for weight
loss. [Letter]. JAMA 1999; 282: 233±234.
24 Firenzuoli F, Gori L. Garcinia cambogia for weight loss. [Letter].
JAMA 1999; 282: 234.
25 Heyms®eld SB, Allison DB, Vasselli JR, Pietrobelli A, Green®eld D,
Nunez C. Garcinia cambogia for weight loss. [Letter]. JAMA 1999;
26 Schaller JL. Garcinia cambogia for weight loss. [Letter]. JAMA
1999; 282: 234.
27 Badmaev V, Majeed M. Open ®eld, physician controlled, clinical
evaluation of botanical weight loss formula citrin. Presented at:
Nutracon 1995: Nutraceuticals, Dietary Supplements and Functional
Foods, Las Vegas, NV, 11±13 July, 1995.
28 Conte AA. A non-prescription alternative in weight reduction
therapy. Am J Bariatr Med 1993; Summer: 17±19.
29 Girola M, de Bernardi M, Contos S, Tripodi S, Ventura P,
Guarino C, Marletta M. Dose effect in lipid-lowering activity of
a new dietary integrator (chitosan, Garcinia cambogia extract and
chrome). Acta Toxicol Ther 1996; 17: 25±40.
30 Thom E, Andrews B. Short- and long-term ef®cacy and
tolerability of (ÿ)-hydroxycitrate in the treatment of
obesity. [Abstract]. Int J Obes Relat Metab Disord 1997; 21(Suppl
31 Westerterp-Plantenga MS, Kovacs EMR. The paradoxical effect of
(ÿ)-hydroxycitrate on energy intake regulation in humans.
[Abstract]. Int J Obes Relat Metab Disord 2000; 24(Suppl 1): S189.
32 Heyms®eld SB, Allison DB, Vasselli, JR, Pietrobelli A, Green®eld D,
Nunez C. Garcinia cambogia (hydroxycitric acid) as a potent
antiobesity agent. JAMA 1998; 280: 1596±1600.
33 Kriketos AD, Thompson HR, Greene H, Hill JO. (ÿ)-Hydroxycitric
acid does not affect energy expenditure and substrate oxidation
in adult males in a post-absorptive state. Int J Obes Relat Metab
Disord 1999; 23: 867±873.
34 Loon L van, Rooijen JJM van, Niesen B, Verhagen H, Saris WHM,
Wagenmakers AJM. Effects of (ÿ)-hydroxycitrate supplementa-
tion on substrate metabolism at rest and during exercise in
humans. Am J Clin Nutr 2000; 72: 1445±1450.
35 Rothacker DQ, Waitmann BE. Effectiveness of Garcinia cambogia
and natural caffeine combination in weight loss Ð a double-blind
placebo-controlled pilot study. [Abstract]. Int J Obes Relat Metab
Disord 1997; 21(Suppl 2): S53.
36 Kovacs EMR, Westerterp-Plantenga MS, de Vries M, Brouns F,
Saris WHM. The effect of chronic ingestion of (ÿ)-hydroxycitrate
and (ÿ)-hydroxycitrate combined with medium-chain triglycer-
ides on satiety (submitted).
37 Bach AC, Babayan VK. Medium-chain triglycerides: an update.
Am J Clin Nutr 1982; 36: 950±962.
38 Beckers EJ, Jeukendrup AE, Brouns F, Wagenmakers AJM,
Saris WHM. Gastric emptying of carbohydrate Ð medium
chain triglyceride solutions in rest. Int J Sports Med 1992; 13:
39 Bremer J. Carnitine Ð metabolism and functions. Physiol Rev
1983; 63: 1420±1479.
(ÿ)-Hydroxycitrate and energy expenditure
International Journal of Obesity